Cardiovascular Involvement in Fabry's Disease: New Advances in Diagnostic Strategies, Outcome Prediction and Management

被引:5
作者
Monda, Emanuele [1 ,2 ]
Falco, Luigi [1 ]
Palmiero, Giuseppe [1 ]
Rubino, Marta [1 ]
Perna, Alessia [1 ]
Diana, Gaetano [1 ]
Verrillo, Federica [1 ]
Dongiglio, Francesca [1 ]
Cirillo, Annapaola [1 ]
Fusco, Adelaide [1 ]
Caiazza, Martina [1 ]
Limongelli, Giuseppe [1 ,2 ,3 ]
机构
[1] Univ Campania Luigi Vanvitelli, Monaldi Hosp, Dept Translat Med Sci, Inherited & Rare Cardiovasc Dis, Naples, Italy
[2] UCL, Inst Cardiovasc Sci, London, England
[3] Univ Campania Luigi Vanvitelli, Inherited & Rare Cardiovasc Dis Clin, Dept Translat Med Sci, Monaldi Hosp,AORN Colli, Via L Bianchi 1, Naples, Italy
关键词
Fabry's disease; hypertrophic cardiomyopathy; diagnosis; outcome; management; ENZYME-REPLACEMENT THERAPY; AGALSIDASE BETA TREATMENT; HUMAN ALPHA-GALACTOSIDASE; QUALITY-OF-LIFE; PEGUNIGALSIDASE ALPHA; SPECKLE-TRACKING; SAFETY; CARDIOMYOPATHIES; SOCIETY; PATIENT;
D O I
10.15420/cfr.2023.06
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular involvement is common in Fabry's disease and is the leading cause of morbidity and mortality. The research is focused on identifying diagnostic clues suggestive of cardiovascular involvement in the preclinical stage of the disease through clinical and imaging markers. Different pathophysiologically driven therapies are currently or will soon be available for the treatment of Fabry's disease, with the most significant benefit observed in the early stages of the disease. Thus, early diagnosis and risk stratification for adverse outcomes are crucial to determine when to start an aetiological treatment. This review describes the cardiovascular involvement in Fabry's disease, focusing on the advances in diagnostic strategies, outcome prediction and disease management.
引用
收藏
页数:7
相关论文
共 79 条
[1]   An Overview of Molecular Mechanisms in Fabry Disease [J].
Amodio, Federica ;
Caiazza, Martina ;
Monda, Emanuele ;
Rubino, Marta ;
Capodicasa, Laura ;
Chiosi, Flavia ;
Simonelli, Vincenzo ;
Dongiglio, Francesca ;
Fimiani, Fabio ;
Pepe, Nicola ;
Chimenti, Cristina ;
Calabro, Paolo ;
Limongelli, Giuseppe .
BIOMOLECULES, 2022, 12 (10)
[2]   Value of Electrocardiography to Distinguish Fabry Disease from Sarcomeric Hypertrophic Cardiomyopathy [J].
Antezana-Chavez, Edgar ;
Francisco Cianciulli, Tomas ;
Leon Hadid, Claudio ;
Di Toro, Dario ;
Celano, Leonardo ;
Cristina Saccheri, Maria ;
Giselle Baez, Karina ;
Alfredo Lopez, Carlos ;
Labadet, Carlos David ;
Alberto Gagliardi, Juan .
AMERICAN JOURNAL OF CARDIOLOGY, 2022, 178 :131-136
[3]   Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis [J].
Beck, Michael ;
Hughes, Derralynn ;
Kampmann, Christoph ;
Larroque, Sylvain ;
Mehta, Atul ;
Pintos-Morell, Guillem ;
Ramaswami, Uma ;
West, Michael ;
Wijatyk, Anna ;
Giugliani, Roberto .
MOLECULAR GENETICS AND METABOLISM REPORTS, 2015, 3 :21-27
[4]   Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis [J].
Cox, T ;
Lachmann, R ;
Hollak, C ;
Aerts, J ;
van Weely, S ;
Hrebícek, M ;
Platt, F ;
Butters, T ;
Dwek, R ;
Moyses, C ;
Gow, I ;
Elstein, D ;
Zimran, A .
LANCET, 2000, 355 (9214) :1481-1485
[5]   Venglustat, an orally administered glucosylceramide synthase inhibitor: Assessment over 3 years in adult males with classic Fabry disease in an open-label phase 2 study and its extension study [J].
Deegan, Patrick B. ;
Goker-Alpan, Ozlem ;
Geberhiwot, Tarekegn ;
Hopkin, Robert J. ;
Lukina, Elena ;
Tylki-Szymanska, Anna ;
Zaher, Atef ;
Sensinger, Charlotte ;
Gaemers, Sebastiaan J. M. ;
Modur, Vijay ;
Thurberg, Beth L. ;
Sharma, Jyoti ;
Najafian, Behzad ;
Mauer, Michael ;
DasMahapatra, Pronabesh ;
Wilcox, William R. ;
Germain, Dominique P. .
MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02)
[6]   Improved Efficacy in a Fabry Disease Model Using a Systemic mRNA Liver Depot System as Compared to Enzyme Replacement Therapy [J].
DeRosa, Frank ;
Smith, Lianne ;
Shen, Yinghua ;
Huang, Yan ;
Pan, Jing ;
Xie, Hongsheng ;
Yahalom, Barak ;
Heartlein, Michael W. .
MOLECULAR THERAPY, 2019, 27 (04) :878-889
[7]   2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J].
Elliott, Perry M. ;
Anastasakis, Aris ;
Borger, Michael A. ;
Borggrefe, Martin ;
Cecchi, Franco ;
Charron, Philippe ;
Hagege, Albert Alain ;
Lafont, Antoine ;
Limongelli, Giuseppe ;
Mahrholdt, Heiko ;
McKenna, William J. ;
Mogensen, Jens ;
Nihoyannopoulos, Petros ;
Nistri, Stefano ;
Pieper, Petronella G. ;
Pieske, Burkert ;
Rapezzi, Claudio ;
Rutten, Frans H. ;
Tillmanns, Christoph ;
Watkins, Hugh .
EUROPEAN HEART JOURNAL, 2014, 35 (39) :2733-+
[8]   Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease. [J].
Eng, CM ;
Guffon, N ;
Wilcox, WR ;
Germain, DP ;
Lee, P ;
Waldek, S ;
Caplan, L ;
Linthorst, GE ;
Desnick, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :9-16
[9]   Layer-specific longitudinal strain in Anderson-Fabry disease at diagnosis: A speckle tracking echocardiography analysis [J].
Esposito, Roberta ;
Santoro, Ciro ;
Sorrentino, Regina ;
Riccio, Eleonora ;
Citro, Rodolfo ;
Buonauro, Agostino ;
Di Risi, Teodolinda ;
Imbriaco, Massimo ;
Trimarco, Bruno ;
Pisani, Antonio ;
Galderisi, Maurizio .
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2019, 36 (07) :1273-1281
[10]   Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naive Anderson-Fabry disease patients [J].
Esposito, Roberta ;
Galderisi, Maurizio ;
Santoro, Ciro ;
Imbriaco, Massimo ;
Riccio, Eleonora ;
Pellegrino, Angela Maria ;
Sorrentino, Regina ;
Lembo, Maria ;
Citro, Rodolfo ;
Losi, Maria Angela ;
Spinelli, Letizia ;
Trimarco, Bruno ;
Pisani, Antonio .
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2019, 20 (04) :438-445